Market Cap (In KRW)
150.87 Billion
Revenue (In KRW)
51.95 Billion
Net Income (In KRW)
-24.81 Billion
Avg. Volume
1.19 Million
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1390.0-2705.0
- PE
- -3.6
- EPS
- -414.03
- Beta Value
- 0.85
- ISIN
- KR7001360007
- CUSIP
- -
- CIK
- -
- Shares
- 94120317.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Won-Kyu Kim
- Employee Count
- -
- Website
- https://www.sspharm.co.kr
- Ipo Date
- 2000-01-04
- Details
- SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, and others, as well as vitamins and energy drinks, and functional foods. The company was founded in 1929 and is based in Hwaseong-si, South Korea.
More Stocks
-
300457
-
RWC
-
SEQI
-
7363baby calendar Inc.
7363
-
5599S&J CORPORATION
5599
-
2379DIP Corporation
2379
-
0592
-
VBNKVersaBank
VBNK